BlackRock UK Equity DI AccRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 15.4 | -5.2 | 13.1 | 7.9 | |
+/-Cat | - | -2.6 | -3.2 | 4.9 | 0.6 | |
+/-B’mrk | - | - | - | 5.4 | -0.3 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 21/11/2024 | GBP 1.48 | |
Day Change | 0.02% | |
Morningstar Category™ | UK Large-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00BFK3MR48 | |
Fund Size (Mil) 31/10/2024 | GBP 334.74 | |
Share Class Size (Mil) - | - | |
Max Initial Charge | - | |
Ongoing Charge 09/02/2024 | 0.47% |
Investment Objective: BlackRock UK Equity DI Acc |
The aim of the Fund is to deliver a return on your investment (generated through an increase to the value of the assets held by the Fund and/or income received from those assets). In order to achieve its investment objective, the Fund will invest at least 80% of its total assets in equities (i.e. shares) of companies located in, or exercising a significant part of their economic activity across all economic sectors in the United Kingdom. The Fund has the flexibility to invest up to 20% of its total assets outside of these parameters, including in other countries globally. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Adam Avigdori 01/12/2022 | ||
Samantha Brownlee 01/12/2022 | ||
Click here to see others | ||
Inception Date 09/07/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE AllSh TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BlackRock UK Equity DI Acc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 7.26 |
RELX PLC | Industrials | 7.04 |
Shell PLC | Energy | 6.10 |
Compass Group PLC | Consumer Cyclical | 5.41 |
3i Group Ord | 4.99 | |
Increase Decrease New since last portfolio | ||
BlackRock UK Equity DI Acc |